BCR Wealth Strategies’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,771
Closed -$224K 38
2025
Q3
$224K Sell
1,771
-1,000
-36% -$119K 0.08% 29
2025
Q2
$339K Sell
2,771
-1,000
-27% -$114K 0.13% 24
2025
Q1
$381K Sell
3,771
-900
-19% -$87.9K 0.17% 20
2024
Q4
$431K Sell
4,671
-2,000
-30% -$196K 0.2% 17
2024
Q3
$644K Sell
6,671
-1,500
-18% -$135K 0.3% 15
2024
Q2
$700K Sell
8,171
-2,000
-20% -$168K 0.46% 12
2024
Q1
$840K Sell
10,171
-958
-9% -$70.2K 0.57% 11
2023
Q4
$742K Hold
11,129
0.53% 12
2023
Q3
$747K Hold
11,129
0.6% 11
2023
Q2
$753K Hold
11,129
0.58% 11
2023
Q1
$602K Hold
11,129
0.48% 11
2022
Q4
$665K Hold
11,129
0.57% 11
2022
Q3
$503K Sell
11,129
-2,860
-20% -$143K 0.52% 12
2022
Q2
$624K Hold
13,989
0.64% 10
2022
Q1
$791K Buy
13,989
+13,536
+2,988% +$707K 0.76% 9
2021
Q4
$23K Buy
+453
New +$23.4K 0.02% 59

Other funds holding EHC

BCR Wealth Strategies's EHC Position: Q4 2025 in Review

BCR Wealth Strategies sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,771 shares — an estimated $224K sold.

BCR Wealth Strategies first reported a position in EHC in Q4 2021 and held it in 16 quarters. The position peaked at $840K in Q1 2024. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • BCR Wealth Strategies reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • BCR Wealth Strategies sold 1,771 Encompass Health shares in Q4 2025, an estimated $224K.
  • BCR Wealth Strategies first reported a position in Encompass Health in Q4 2021 and held it in 16 quarters.
  • BCR Wealth Strategies's Encompass Health position peaked at $840K in Q1 2024.
  • 593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on BCR Wealth Strategies's 13F filing for Q4 2025, filed 23 Jan 2026.